DEF 14AAEONCIK 0001837607

AEON Biopharma, Inc.

Name: SEC EDGAR filing 0001837607-26-000074
Creator: AEON Biopharma, Inc.
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed October 26, 2026.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Open the filing on SEC.gov

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number: 0001837607-26-000074
Filer: AEON Biopharma, Inc.
Ticker: AEON
CIK: 0001837607
Form type: DEF 14A
Form description: Proxy statement
Filed at: October 26, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: October 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from AEON Biopharma, Inc.

8-KMaterial eventSep 30, 2026

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1837607/000183760726000074/0001837607-26-000074-index.htm ↗

Filer's full EDGAR submission history

EDGAR · AEON Biopharma, Inc. (0001837607) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001837607-26-000074.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.